Yahoo Suche Web Suche

Suchergebnisse

1. Suchergebnisse:

1. www.pharmnews.com › news › articleViewChina Medical University Hospital (CMUH, Taiwan) Signs MOU with...

   www.pharmnews.com › news › articleView

   • Im Cache

   Vor 17 Stunden · According to Aichi Chou, CEO of the International Center at CMUH, CMUH's leading medical treatments, including brain cancer therapy, minimally invasive cardiac procedures for various cardiovascular diseases (atrial fibrillation, arrhythmia, aortic valve replacement, peripheral vascular occlusion, etc.), non-invasive treatment for severe tremors using "MRgFUS (Magnetic Resonance-guided Focused ...

2. finance.yahoo.com › news › encouraging-data-presented-kiteEncouraging New Data Presented on Kite’s Yescarta® for Relapsed...

   finance.yahoo.com › news › encouraging-data-presented-kite

   • Im Cache

   Vor 17 Stunden · SANTA MONICA, Calif., June 03, 2024--Kite, a Gilead Company (Nasdaq: GILD), announced data from a pilot study in collaboration with Dana-Farber Cancer Institute that demonstrate Yescarta ...

3. in.marketscreener.com › quote › stockEncouraging New Data Presented on Kite’s Yescarta® for Relapsed...

   in.marketscreener.com › quote › stock

   • Im Cache

   Vor 15 Stunden · 24.gSg5K7_1wq_t6UUunXvnjFiAVzzdU0vsWcCn8UwCb5c.6kx6RYad7961qiBt_hCEwmm2ek-tZyOLKpXelSk1KsLvfFxM3sy0zIKwMg

4. business.times-online.com › times-online › articleModerna & Merck Announce 3-Year Data For mRNA-4157 (V940) in ...

   business.times-online.com › times-online › article

   • Im Cache

   Vor 5 Stunden · Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survival Versus KEYTRUDA in Patients With High-Risk Stage